Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNN.31.19.026 vs Cosopt in Ocular Hypertension or Primary Open-Angle Glaucoma
NCT07617532Phase 3Not yet recruiting
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jun 2026
- Primary completion
- Mar 2028
01
Overview
Phase 3, randomised trial in ocular hypertension and primary open-angle glaucoma (POAG) (2 arms), sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Diurnal Intraocular Pressure at 56 days. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
ocular hypertensionprimary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT07617532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07617532.